510(k) K153481

0.9% Sodium Chloride Injection, USP BD PosiFlush SF Syringe by Becton, Dickinson and Company — Product Code NGT

K153481 is an FDA 510(k) premarket notification submitted by Becton, Dickinson and Company for the device "0.9% Sodium Chloride Injection, USP BD PosiFlush SF Syringe". The FDA issued a decision of Substantially Equivalent on April 4, 2016. The device falls under product code NGT (Saline, Vascular Access Flush), a Class II device regulated under 21 CFR 880.5200. Becton, Dickinson and Company has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
April 4, 2016
Date Received
December 3, 2015
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Saline, Vascular Access Flush
Device Class
Class II
Regulation Number
880.5200
Review Panel
HO
Submission Type

Enhance the performance of intravascular catheters, to maintain patency of the vascular catheter when it is not in use.